Psychedelic-Assisted Therapy for Depression, PTSD, and Anxiety: Benefits, Risks, and What Research Shows
Imagine struggling with depression for years and trying medication after medication without finding meaningful relief.
For millions of people living with treatment-resistant depression, traditional approaches may not always provide the improvement they hope for. Researchers are increasingly exploring psychedelic-assisted therapy as a potential treatment for depression, anxiety, post-traumatic stress disorder (PTSD), and other mental health concerns.
Nearly half of individuals experiencing depression do not respond adequately to at least two antidepressant medications, a condition often referred to as treatment-resistant depression (Saelens et al., 2025). As mental health professionals continue searching for effective treatment options, psychedelic-assisted therapy has emerged as one of the most discussed and researched developments in modern psychology.
While psychedelic-assisted therapy remains an emerging treatment option, many of the concerns it seeks to address—including depression, trauma, anxiety, grief, and emotional distress—can often be effectively treated through evidence-based counseling approaches available today.
What Is Psychedelic-Assisted Therapy?
Psychedelic-assisted therapy (PAT) is an emerging mental health intervention that combines carefully supervised use of psychedelic substances with structured psychotherapy. Some of the substances studied in research settings include psilocybin (commonly known as "magic mushrooms") and MDMA.
Unlike recreational drug use, psychedelic-assisted therapy occurs within a controlled therapeutic environment. Clients typically participate in preparation sessions before treatment, monitored experiences during treatment, and follow-up integration sessions designed to help them process and apply insights gained from the experience.
One meta-analysis examining 12 studies involving 733 participants found substantial reductions in depressive symptoms among individuals who received psychedelic-assisted therapy (Florineth et al., 2026).
How Does Psychedelic-Assisted Therapy Work?
Researchers believe psychedelic substances may temporarily alter patterns of brain activity associated with rigid thinking, emotional avoidance, and chronic psychological distress. Some studies suggest these substances may increase psychological flexibility and emotional openness, allowing individuals to process difficult experiences in new ways.
The therapeutic process typically involves three stages:
Preparation sessions with a therapist.
A monitored psychedelic experience.
Integration therapy afterward to process insights and emotional experiences.
Researchers continue studying exactly how these treatments affect the brain and whether long-term benefits can be maintained over time.
What Conditions Has Psychedelic-Assisted Therapy Been Shown to Help?
Depression
The strongest body of current evidence focuses on depression, particularly treatment-resistant depression. Multiple studies have demonstrated significant reductions in depressive symptoms following psychedelic-assisted interventions (Florineth et al., 2026).
Anxiety
Research has also found promising results for individuals experiencing anxiety disorders and chronic anxiety symptoms. Some studies indicate improvements may persist for extended periods after treatment (Li et al., 2025).
Post-Traumatic Stress Disorder (PTSD)
Psychedelic-assisted therapy has demonstrated potential benefits for individuals experiencing PTSD and trauma-related symptoms. Researchers have increasingly explored trauma-informed approaches to psychedelic therapy as a way to help individuals process traumatic experiences in a supportive setting (Modlin et al., 2024).
Suicidal Thoughts
Emerging evidence suggests psychedelic-assisted therapy may contribute to reductions in suicidal thinking among some participants when administered in clinical settings alongside psychotherapy (Zeifman et al., 2022).
End-of-Life Distress
Research has also explored psychedelic-assisted therapy as a way to reduce existential distress, anxiety, and emotional suffering among individuals facing terminal illness (Marchi et al., 2024).
Is Psychedelic Therapy Legal?
The legal status of psychedelic-assisted therapy varies depending on the substance and jurisdiction. While research involving psilocybin and MDMA continues to expand, many psychedelic substances remain federally regulated in the United States.
Individuals interested in psychedelic-assisted therapy should seek information from qualified healthcare professionals and avoid attempting self-treatment. Regulations continue to evolve as new research becomes available.
What Are the Risks?
Although research findings have generally shown favorable safety outcomes within controlled clinical environments, psychedelic-assisted therapy is not without risks.
Potential concerns include:
Temporary increases in heart rate and blood pressure
Anxiety or panic during treatment sessions
Emotional distress while processing difficult experiences
Rare cases of prolonged psychological symptoms
A systematic review by Romeo et al. (2024) found relatively few serious adverse events during clinical psychedelic therapy research. However, researchers emphasize that proper screening, supervision, and follow-up care are essential components of safe treatment.
Psychedelic-assisted therapy may not be appropriate for everyone. Individuals with certain psychotic disorders, bipolar disorders, or significant cardiovascular conditions may face increased risks. Careful evaluation by qualified medical and mental health professionals remains critical.
How Counseling Continues to Play an Important Role
Although psychedelic-assisted therapy has received significant attention, traditional counseling remains one of the most effective and accessible forms of mental health treatment available today.
Many individuals struggling with depression, anxiety, trauma, grief, relationship challenges, and life transitions benefit from evidence-based approaches such as:
Cognitive Behavioral Therapy (CBT)
Acceptance and Commitment Therapy (ACT)
Trauma-Informed Therapy
Dialectical Behavior Therapy (DBT)
Mindfulness-Based Interventions
For many people, psychotherapy alone continues to provide meaningful and lasting improvement.
Mental Health Support in Illinois
If you are struggling with depression, anxiety, trauma, or emotional distress, professional counseling can help. Evidence-based therapy can provide practical tools, emotional support, and personalized treatment strategies designed to improve mental health and overall quality of life.
Individuals throughout Chicago's Rogers Park, and Chicago can access counseling services through in-person and telehealth appointments.
Take the Next Step
Whether you are exploring emerging mental health treatments or seeking proven counseling approaches, you do not have to navigate emotional challenges alone.
If you are experiencing depression, anxiety, trauma, grief, or relationship difficulties, professional support is available.
Schedule an appointment with a counselor at counselingappointments.com or call (708) 275-0934 to learn more about available services. See the schedule of the therapist Matteo Russionello and make an appointment for counseling or psychotherapy this week at http://www.rogersparkcounselors.com
References
Florineth, G. A., et al. (2026). Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis. JAMA Network Open.
Li, J.-R., et al. (2025). The association between study design and antidepressant effects in psychedelic-assisted therapy. Journal of Affective Disorders.
Marchi, M., et al. (2024). Psychedelics as an intervention for existential distress in terminally ill patients. Journal of Psychopharmacology.
Modlin, N. L., et al. (2024). Trauma-Informed Care in Psychedelic Therapy Research. Neuropsychiatric Disease and Treatment.
Romeo, B., et al. (2024). Safety and risk assessment of psychedelic psychotherapy. Psychiatry Research.
Saelens, J., et al. (2025). Relative effectiveness of antidepressant treatments in treatment-resistant depression. Neuropsychopharmacology.
Zeifman, R. J., et al. (2022). Decreases in Suicidality Following Psychedelic Therapy. The Journal of Clinical Psychiatry.